{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:24:37Z","timestamp":1783974277493,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T00:00:00Z","timestamp":1450915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T00:00:00Z","timestamp":1450915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1038\/ijir.2015.22","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T09:00:29Z","timestamp":1450947629000},"page":"41-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Topical treatment for acute phase Peyronie\u2019s disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study"],"prefix":"10.1038","volume":"28","author":[{"given":"J","family":"Twidwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,24]]},"reference":[{"key":"BFijir201522_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","volume":"7","author":"D Ralph","year":"2010","unstructured":"Ralph D, Gonzales-Cadavid N, Mirone V, Perevic S, Sohn M, Usta M et al. The management of Peyronie\u2019s disease: evidence-based 2010 guidelines. J Sex Med 2010; 7: 2359\u20132374.","journal-title":"J Sex Med"},{"key":"BFijir201522_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2164\/jandrol.108.006221","volume":"30","author":"W Hellstrom","year":"2009","unstructured":"Hellstrom W . Medical management of Peyronie\u2019s disease. J Androl 2009; 30: 397\u2013405.","journal-title":"J Androl"},{"key":"BFijir201522_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J et al. Clinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie's disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol 2013; 190: 199\u2013207.","journal-title":"J Urol"},{"key":"BFijir201522_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1440-0960.1996.tb01040.x","volume":"37","author":"A Zemtsov","year":"1996","unstructured":"Zemtsov A, Gaddis M, Montalvo-Lugo V . Moisturizing and Cosmetic Properties of Emu Oil: A Double Blind Study. Australas J Dermatol 1996; 37: 159\u2013161.","journal-title":"Australas J Dermatol"},{"key":"BFijir201522_CR5","first-page":"407","volume":"25","author":"XW Qiu","year":"2005","unstructured":"Qiu XW, Wang JH, Fang XW, Gong ZY, Li ZQ, Yi ZH . Anti-inflammatory activity and healing-promoting effects of topical application of emu oil on wound in scalded rats. [Article in Chinese]. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 407\u2013410.","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"BFijir201522_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1023\/A:1022986331231","volume":"16","author":"F Kouoh","year":"2002","unstructured":"Kouoh F, Gressier B, Dine T, Luyckx M, Brunet C, Ballester L et al. Antioxidant effects and anti-elastase activity of the calcium antagonist nicardipine on activated human and rabbit neutrophils\u2014a potential antiatherosclerotic property of calcium antagonists? Cardiovasc Drugs Ther 2002; 16: 515\u2013520.","journal-title":"Cardiovasc Drugs Ther"},{"key":"BFijir201522_CR7","doi-asserted-by":"publisher","first-page":"16001619","DOI":"10.1164\/rccm.200212-1479SO","volume":"167","author":"V Kinnula","year":"2003","unstructured":"Kinnula V, Crapo JD . Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med 2003; 167: 16001619.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFijir201522_CR8","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1111\/jsm.12334","volume":"10","author":"L Levine","year":"2013","unstructured":"Levine L, Rybak J, Corder C, Farrel MR . Peyronie\u2019s disease plaque calcification-prevalence, time to identification, and development of a new grading classification. J Sex Med 2013; 10: 3121\u20133128.","journal-title":"J Sex Med"},{"key":"BFijir201522_CR9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","volume":"5","author":"C Nelsen","year":"2008","unstructured":"Nelsen C, Diblasio C, Kendirci M, Hellstrom W, Gurhing P, Mulhall J . The chronology of depression and distress in men with Peyronie\u2019s disease. J Sex Med 2008; 5: 1985\u20131990.","journal-title":"J Sex Med"},{"key":"BFijir201522_CR10","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/S0022-5347(05)64173-0","volume":"168","author":"DJ Martin","year":"2002","unstructured":"Martin DJ, Badwan K, Parker M, Mulhall JP . Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea. J Urol 2002; 168: 2483\u20132485.","journal-title":"J Urol"},{"key":"BFijir201522_CR11","first-page":"450","volume":"6","author":"P Smith","year":"1995","unstructured":"Smith P, Craig-Schmidt M, Brown A . Fatty acid analysis of emu oil. INFORM 1995; 6: 450.","journal-title":"INFORM"},{"key":"BFijir201522_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s11745-003-1104-y","volume":"38","author":"S Yoganathan","year":"2003","unstructured":"Yoganathan S, Nicolosi R, Wilson T, Handelman G, Scollin P, Tao R et al. Antagonism of croton oil inflammation by topical emu oil in CD-1 mice. Lipids 2003; 38: 603\u2013607.","journal-title":"Lipids"},{"key":"BFijir201522_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1743-6109.2006.00417.x","volume":"4","author":"WP Fitch","year":"2007","unstructured":"Fitch WP, Easterling WJ, Talbert RL, Bordovsky MJ, Mosier M . Topical verapamil HCL, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie\u2019s disease-a placebo-controlled pilot study. J Sex Med 2007; 4: 477\u2013484.","journal-title":"J Sex Med"},{"key":"BFijir201522_CR14","doi-asserted-by":"publisher","first-page":"168621","DOI":"10.1016\/S0022-5347(05)64691-5","volume":"168","author":"L Levine","year":"2002","unstructured":"Levine L, Goldman K, Greenfield J . Experience with intraplaque injection of verapamil for Peyronie\u2019s disease. J Urol 2002; 168: 168621\u2013168626.","journal-title":"J Urol"},{"key":"BFijir201522_CR15","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","volume":"7","author":"J Soh","year":"2010","unstructured":"Soh J, Kawauchi A, Kanemitsu N, Naya Y, Ochial A, Naltoh Y et al. Nicardipine vs saline injection as treatment for Peyronie\u2019s disease: a prospective, randomized, single-blind study. J Sex Med 2010; 7: 3743\u20133749.","journal-title":"J Sex Med"},{"key":"BFijir201522_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1159\/000138932","volume":"44","author":"H Gurdal","year":"1992","unstructured":"Gurdal H, Sara Y, Tulunay FC . Effects of calcium channel blockers on formalin-induced nociception and inflammation in rats. Pharmacology 1992; 44: 290\u2013296.","journal-title":"Pharmacology"},{"key":"BFijir201522_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0309-1651(78)90032-2","volume":"2","author":"B Halliwell","year":"1978","unstructured":"Halliwell B . Biochemical mechanisms accounting for the toxic action of oxygen on living organisms: the key role of superoxide dismutase. Cell Biol Int Rep 1978; 2: 113\u2013128.","journal-title":"Cell Biol Int Rep"},{"key":"BFijir201522_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.eururo.2005.04.011","volume":"48","author":"C Riedl","year":"2005","unstructured":"Riedl C, Sternig P, Galle G, Langmann F, Vcelar B, Vorauer K et al. Liposomal recombinant human superoxide dismutase for the treatment of Peyronie\u2019s disease: a randomized placebo-controlled double-blind prospective clinical study. Eur Urol 2005; 48: 656\u2013661.","journal-title":"Eur Urol"},{"key":"BFijir201522_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","volume":"10","author":"L Levine","year":"2013","unstructured":"Levine L, Burnett A . Standard operating procedures for Peyronie's disease. J Sex Med 2013; 10: 230\u2013244.","journal-title":"J Sex Med"}],"updated-by":[{"DOI":"10.1038\/s41443-020-0303-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T00:00:00Z","timestamp":1591056000000}}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201522","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:44:40Z","timestamp":1648658680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,24]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["BFijir201522"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2015.22","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,24]]},"assertion":[{"value":"12 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41443-020-0303-z","URL":"https:\/\/doi.org\/10.1038\/s41443-020-0303-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}